Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib

Study ID: NCT07075471
Start Date: 2025-09-03
End Date: 2027-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

Deciphera Pharmaceuticals, LLC

Source: clinicaltrials.gov

Share:
Add to list

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

Study ID: NCT05641831
Start Date: 2023-02-06
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

110

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration and Biopsy

canakinumab

Chest Radiography

Echocardiography

Placebo Administration

Quality-of-Life Assessment

Sponsor

A Borate

Source: clinicaltrials.gov

Share:
Add to list

HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

Study ID: NCT06594445
Start Date: 2024-11-19
End Date: 2027-10-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

45

Intervention / Treatment

GTB-360

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

Study ID: NCT07148245
Start Date: 2025-10-13
End Date: 2027-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Blood Sample

Health Related Quality of Life Questionnaires (HRQoL)

Medical Chart Review

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

Study ID: NCT05607095
Start Date: 2022-11-01
End Date: 2026-05-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Lifileucel (LN-144/LN-145)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

Study ID: NCT06590961
Start Date: 2025-02-20
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

94

Intervention / Treatment

UBX-303061

Sponsor

Ubix Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

4D-MRI for Precision Medicine

Study ID: NCT04657042
Start Date: 2020-11-05
End Date: 2030-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Magnetic Resonance Imaging

Sponsor

University of Virginia

Source: clinicaltrials.gov

Share:
Add to list

Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma

Study ID: NCT05083754
Start Date: 2022-08-31
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

Retifanlimab

Temozolomide

Radiation Therapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Dental Implant Healing With TNF-Alpha Inhibitors

Study ID: NCT06538870
Start Date: 2025-01-28
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Placement of dental implants

Sponsor

University of Pennsylvania

Source: clinicaltrials.gov

Share:
Add to list

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Study ID: NCT06430541
Start Date: 2024-11-21
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Psilocybin

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list